Enhanced expression and clinical significance of CC-chemokine MIP-3α in hepatocellular carcinoma

Scandinavian Journal of Immunology

Volumn 63, Issue 6, 2006, Pages 468-477

  Rubie, C ^a,b   Frick, V O ^a   Wagner, M ^a   Rau, B ^a   Weber, C ^a   Kruse, B ^a   Kempf, K ^a   Tilton, B ^a   Konig J ^a   Schilling, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MICRODISSECTION; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOKINES, CC; FEMALE; HUMANS; LIVER NEOPLASMS; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; TUMOR MARKERS, BIOLOGICAL;

EID: 33745558196     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.001766.x     Document Type: Article

References (50)

1. Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003;9:1885-91.
2. Zhu AX. Hepatocellular Carcinoma: are we making progress? Cancer Invest 2003;21:418-28.
3. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
4. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1-17.
5. Rossi D, Slotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
6. Liu Y, Poon RT, Hughes J, Feng X, Yu WC, Fan ST. Chemokine receptors support infiltration of lymphocyte sub populations in human hepatocellular carcinoma. Clin Immunol 2005;114:174-82.
7. Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6.
8. Schimanski C, Schwald S, Simiantonaki N et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005;11:1743-50.
9. Gunn M. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-63.
10. Takeushi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 Chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004;10:2351-8.
11. Mashino K, Sadanaga N, Yamaguchi H et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002;62:2937-41.
12. Günther K, Leier L, Henning G et al. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 2005;116:726-33.
13. Förster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
14. Ohl L, Henning G, Krautwald S et al. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med 2003;197:1199-204.
15. Bleul CC. The lymphocyte chemoattractant SDF1-α is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
16. Ishikawa T, Nakashiro K, Hara S et al. CXCR4 expression is associated with lymph node metastasis of oral squamous cell carcinoma. Int J Oncol 2006;28:61-6.
17. Hu J, Deng X, Bian X et al. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of Human Nasopharyngeal Carcinoma. Clin Cancer Res 2005;11:4658-65.
18. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62: 1832-7.
19. Geminder H, Sagi-Assif O, Goldberg L et al. A possible role for CXCR4 and its ligand the CXC chemokine stromal cell-derived factor-1 in the development of bone marrow metatases in neuroblastoma. J Immunol 2001;167:4747-57.
20. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003;63:3833-9.
21. Burger M, Glodek A, Hartmann T et al. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 2003;22:8093-101.
22. Hieshima K, Imai T, Opdenakker G et al. Molecular cloning of a novel human CC chemokine liver and activation regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997;272:5846-53.
23. Kimsey TF, Campbell AS, Albo D, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J 2004;10:374-80.
24. Greaves DR, Wang W, Dairaghi DJ et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 1997;186:837-44.
25. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber HM. CC-chemokine receptor CCR6 is expressed on diverse subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J Immunol 1999;162:186-94.
26. Krzysiek R, Lefevre EA, Bernard J et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3α/CCL20 in human B cells. Blood 2000;96:2338-45.
27. Shimuzu Y, Murata H, Kashii Y et al. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001;34:311-9.
28. Liu Y, Poon RT, Feng X, Yu WC, Luk JM, Fan ST. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Am J Gastroenterol 2004;99:1111-21.
29. Yamauchi K, Fazle Akbar SM, Horiike N, Michitaka K, Onji M. Increased serum levels of macrophage inflammatory protein-3α in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy. Int J Mol Med 2003;11:601-5.
30. Dellacasagrande J, Schreurs OJ, Hofgaard PO et al. Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol 2003;57:534-44.
31. Uchida H, Iwashita Y, Sasaki A et al. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 2006;21:161-8.
32. UICC. TNM Classification of Malignant Tumors, 5th edn. New York: Wiley-Liss, 1997.
33. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
34. Rubie C, Kempf K, Hans J et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005;19:101-9.
35. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-62.
36. Mitra P, Shibuta K, Mathai J et al. CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. Int J Oncol 1999;14:917-25.
37. Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard G. Regional expression of CXCL12/CXCR4: Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation. Jpn J Cancer Res 2002;93:789-97.
38. Mirshahi F, Pourtau J, Li H et al. SDF-1 activity on microvascular endothelial cells. Consequences on angiogenesis in in vitro and in vivo models. Thromb Res 2000;99:587-94.
39. Vianello F, Papeta N, Chen T et al. Murine B16 Melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol 2006;176:2902-14.
40. Nomura T, Hasegawa H, Kohno M et al. Enhancement of antitumor immunity by tumor cells transfected with secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor 1-a chemokine genes. Int J Cancer 2001;91:597-606.
41. Dunussi-Joannopoulos K, Zuberek K, Runyon K et al. Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. Blood 2002;100:1551-8.
42. Shi M, Hao S, Su L et al. Vaccine of engineered tumor cells secreting stromal cell-derived factor-1 induces T-cell dependent antitumor responses. Cancer Biother Radiopharm 2005;20:401-9.
43. Crazzolara R, Kreczy A, Mann G et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol 2001;115:545-53.
44. Kim J, Takeuchi H, Lam ST et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recur-rence and for poor survival. J Clin Oncol 2005;23:2744-53.
45. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 2003;105:186-9.
46. Yang SC, Batra RK, Hillinger S et al. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduced tumor burden in spontanious murine bronchoalveoloar cell carcinoma. Cancer Res 2006;66:3205-13.
47. Bonnotte B, Crittenden M, Larmonier N, Gough M, Vile RG. MIP-3α Transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity. J Immunol 2004;173: 4929-35.
48. Fushimi T, Kojima A, Moore M, Crystal RG. Macrophage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J Clin Invest 2000;105:1383-93.
49. Ye QH, Qin LX, Forgues M et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003;9:416-23.
50. Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW. The molecular signature of metastases of human hepatocellular carcinoma. Oncology 2005;69:23-7.